Title
Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity.
Abstract
Protein arginine methyltransferase 5 (PRMT5) is responsible for the mono-methylation and symmetric dimethylation of arginine, and its expression level and methyl transferring activity have been demonstrated to have a close relationship with tumorigenesis, development and poor clinical outcomes of human cancers. Two PRMT5 small molecule inhibitors (GSK3326595 and JNJ-64619178) have been put forward into clinical trials. Here, we describe the design, synthesis and biological evaluation of a series of novel, potent and selective PRMT5 inhibitors with antiproliferative activity against Z-138 mantle cell lymphoma cell line. Among them, compound C_4 exhibited the highest potency with enzymatic and cellular level IC50 values of 0.72 and 2.6 μM, respectively, and displayed more than 270-fold selectivity toward PRMT5 over several other isoenzymes (PRMT1, PRMT4 and PRMT6). Besides, C_4 demonstrated obvious cell apoptotic effect while reduced the cellular symmetric arginine dimethylation levels of SmD3 protein. The potency, small size, and synthetic accessibility of this compound class provide promising hit scaffold for medicinal chemists to further explore this series of PRMT5 inhibitors.
Year
DOI
Venue
2019
10.1007/s10822-019-00214-y
Journal of Computer-Aided Molecular Design
Keywords
Field
DocType
PRMT5 inhibitor, Anti-proliferative, Cellular target validation, Design and synthesis
Cell culture,IC50,Protein arginine methyltransferase 5,Enzyme,Biochemistry,Computational chemistry,Small molecule,Chemistry,Cell,Rational design,Arginine
Journal
Volume
Issue
ISSN
33
8
0920-654X
Citations 
PageRank 
References 
0
0.34
0
Authors
7
Name
Order
Citations
PageRank
Kongkai Zhu111.37
Jingwei Shao200.34
Hongrui Tao300.34
Xue Yan400.34
Cheng Luo5297.86
Hua Zhang600.34
Wenhu Duan700.34